Insider Transactions in Q4 2020 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,000
-2.96%
|
$161,000
$23.11 P/Share
|
|
Dec 16
2020
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.83%
|
$42,000
$12.15 P/Share
|
|
Nov 17
2020
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
4,716
-1.81%
|
$89,604
$19.77 P/Share
|
|
Nov 17
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
1,648
-1.39%
|
$31,312
$19.77 P/Share
|
|
Nov 17
2020
|
Utpal Koppikar Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,469
-1.1%
|
$27,911
$19.77 P/Share
|
|
Nov 13
2020
|
Joe Newell Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.01%
|
$135,000
$18.74 P/Share
|
|
Nov 13
2020
|
Joe Newell Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+2.71%
|
$42,000
$12.15 P/Share
|